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Abstract: 
Background: Increased cancer risk has been reported among workers in 
the rubber manufacturing industry employed before the 1960s. It is 
unclear whether risk remains increased among workers hired subsequently. 
The present study focused on risk of cancer mortality for rubber workers 
first employed since 1975 in 64 factories.  
Patients and methods: Anonymised data from cohorts of rubber workers 
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employed for at least one year from Germany, Italy, Poland, Sweden and 
the United Kingdom were pooled. Standardised mortality ratios (SMRs), 
based on country-specific death rates, were reported for bladder and lung 
cancer (primary outcomes of interest), for other selected cancer sites, and 
for cancer sites with a minimum of 10 deaths in men or women. Analyses 
stratified by type of industry, period and duration of employment were 
performed.  
Results: 38,457 individuals (29,768 men; 8,689 women) contributed to 
949,370 person-years. No increased risk of bladder cancer was observed 
(SMR=0.80, 95%CI (0.46; 1.38)). The risk of lung cancer death was 
reduced (SMR=0.81, 95%CI (0.70; 0.94)). No statistically significant 
increased risk was observed for any other cause of death. A reduced risk 
was evident for total cancer mortality (SMR=0.81, 95%CI (0.76; 0.87)). 
Risks were lower for workers in the tyre industry compared to workers in 
the general rubber goods sector. Analysis by employment duration showed 
a negative trend with SMRs decreasing with increasing duration of 
employment. In an analysis of secondary endpoints, when stratified by 
type of industry and period of first employment, excess risks of myeloma 
and gastric cancer were observed each due, essentially, to results from one 
centre.  
Conclusion: No consistent increased risk of cancer death was observed 
among rubber workers first employed since 1975, no overall analysis of the 
pooled cohort produced significantly increased risk. Continued surveillance 
of the present cohorts is required to confirm absence of long-term risk.  
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Abstract (298 words) 
Background: Increased cancer risk has been reported among workers in the rubber manufacturing 
industry employed before the 1960s. It is unclear whether risk remains increased among workers 
hired subsequently. The present study focused on risk of cancer mortality for rubber workers first 
employed since 1975 in 64 factories. 
Patients and methods: Anonymised data from cohorts of rubber workers employed for at least one 
year from Germany, Italy, Poland, Sweden and the United Kingdom were pooled. Standardised 
mortality ratios (SMRs), based on country-specific death rates, were reported for bladder and lung 
cancer (primary outcomes of interest), for other selected cancer sites, and for cancer sites with a 
minimum of 10 deaths in men or women. Analyses stratified by type of industry, period and duration 
of employment were performed.  
Results: 38,457 individuals (29,768 men; 8,689 women) contributed to 949,370 person-years. No 
increased risk of bladder cancer was observed (SMR=0.80, 95%CI (0.46; 1.38)). The risk of lung 
cancer death was reduced (SMR=0.81, 95%CI (0.70; 0.94)). No statistically significant increased risk 
was observed for any other cause of death. A reduced risk was evident for total cancer mortality 
(SMR=0.81, 95%CI (0.76; 0.87)). Risks were lower for workers in the tyre industry compared to 
workers in the general rubber goods sector. Analysis by employment duration showed a negative 
trend with SMRs decreasing with increasing duration of employment. In an analysis of secondary 
endpoints, when stratified by type of industry and period of first employment, excess risks of 
myeloma and gastric cancer were observed each due, essentially, to results from one centre. 
Conclusion: No consistent increased risk of cancer death was observed among rubber workers first 
employed since 1975, no overall analysis of the pooled cohort produced significantly increased risk. 
Continued surveillance of the present cohorts is required to confirm absence of long-term risk. 
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Key message:  
In a prospective cohort of 38,457 workers employed since 1975 in the European rubber 
manufacturing industry and followed on average for 26 years, no consistent increased risk of cancer 
death was observed. Although the findings from this study are reassuring, continued surveillance of 
the present cohorts is required to confirm absence of long-term risk. 
 
Introduction 
  Epidemiological studies have reported increased risk of bladder cancer and leukaemia 
among workers in the rubber manufacturing industry mainly among those employed before the 
1960s: these excess risks have been associated with exposure to aromatic amines, and solvents, 
respectively [1]. A narrative (qualitative) review of epidemiological studies published up to 1997 
concluded that bladder, laryngeal, lung cancer and leukaemia were the cancers with an increased 
risk among rubber workers, with howev r evidence of substantial heterogeneity of results [2]. 
However, a meta-analysis based on cohort studies published through 2003 showed no excess risk for 
any of the cancer sites although there was not differentiation made between natural rubber and 
synthetic rubber (styrene butadiene) [3]. Recently, the IARC has re-evaluated the rubber industry, 
and has classified rubber production as a group 1 carcinogen for cancers of the stomach, the lung 
and lymphoma in addition to bladder cancer and leukaemia [4], employing all data available 
irrespective of the period of exposure. 
  The rubber manufacturing industry, which employed approximately 380,000 workers in EU-
15 in 1990-1993 [5], has undergone radical technological changes since the 1950s, entailing major 
reductions in rubber dust and fume exposure or the removal of known carcinogenic agents, although 
the changes in technology were gradual and took place at variable pace in different countries. Data 
collected by the EU-ExAsRub consortium in the rubber manufacturing industry showed a general 
reduction in the exposure of workers to inhalable dust from the 1970s to 2003 however with marked 
differences between countries [6]. These results are of interest but are of an ecological nature and 
such data are not available on a personal level.  
 Two studies of workers first employed after 1980 in the rubber manufacturing industry in 
Germany [7] and United Kingdom [8] showed no excess risk of overall cancer mortality, as well as 
bladder, stomach and lung cancers. The present study reports data on risk of death from cancer and 
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major causes of death from a large-scale epidemiologic study of workers first employed since 1975 
in the rubber manufacturing industry from five European countries. This study provides therefore a 
direct evaluation of risk of cancer in the modern rubber manufacturing industry. 
 
Material and methods 
  A protocol specifying inclusion criteria and a detailed statistical analysis plan was prepared 
between local principal investigators of the present study prior to data analysis (available upon 
request from corresponding author). The cohort consisted of rubber workers employed in Germany, 
Italy, Poland, Sweden and the United Kingdom. Workers were included if they (i) were employed for 
at least one year in one f the cohorts, and (ii) had a first employment in the rubber manufacturing 
industry at 1st of January 1975 or later. This first employment period varied from country to country, 
being 1981 for the German cohort, 1982 for United Kingdom and 1975 for all other countries. 
Factories were distributed throughout all regions in Poland, Sweden and the United Kingdom. For 
Italy, workers were employed in factories of the north of Italy: in the region of Piemonte (Italy). For 
Germany, workers were employed in factories located in western Germany in the Federal States of 
Lower Saxony and North Rhine–Westphalia. 
  For all countries but Germany, follow-up data were complete until a right censoring date 
(Table 1). For Germany, the follow-up data and vital status was complete until 2000, and from 2001 
to 2003, cause of death and migration status was missing for the majority of workers. The period 
2001-2003 was therefore excluded from the analysis for Germany. From 2004 to 2012 vital status 
became partially available and enabled evaluating vital status and causes of death. In order to avoid 
underestimation of mortality rates, correction factors, depending on migration and risk of deaths 
from all causes, were applied to person-years from 2001 onward. These correction factors were 
estimated from the 2,042 workers in Hannover city for which complete information on vital status 
and migration was available. Sensitivity analyses were conducted to evaluate the influence of these 
correction factors. 
  The primary outcomes of interest were mortality from bladder cancer and lung cancer. 
Secondary outcomes were mortality from all cancers combined, stomach cancer, leukaemia, 
multiple myeloma and non-Hodgkin lymphoma (NHL). Exploratory outcomes included all other 
neoplasms with more than ten observed deaths in men or women in the combined analysis and 
mortality from cardiovascular diseases, respiratory diseases (without pneumonia) and all-causes. If 
an exploratory outcome was considered for a particular site, the SMR for the other gender group 
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was reported only if the number of deaths was greater than five. The list of ICD-9 codes used in the 
present article is reported in supplementary table 1 (S-Table 1). 
  The observed numbers of deaths for each cause of death considered was compared with the 
expected number calculated on the basis of national or regional (Italy) gender, age- and period-
specific mortality rates. Five-year age groups were used for age and time period. National reference 
rates were obtained from the WHO Mortality Database (Revision of November 2014). For Italy, 
reference rates could be obtained from the region of Piedmont. Data from the Central Statistical 
Office of Poland were used when data from the WHO mortality database were not available (earlier 
years for a few cancer sites). For each country, standardized mortality ratios (SMRs, i.e., the ratio of 
observed to expected deaths) were calculated together with their confidence intervals based on the 
Poisson distribution of observed deaths [9, 10]. Country-specific SMRs were combined using 
random-effects models [11], which take into account potential heterogeneity among cohorts. Forest 
plots were reported for bladder and lung cancer mortality (primary outcomes) to evaluate the 
relative contribution of each country in the overall risk estimate. 
Measures of heterogeneity was reported using I2 statistics [12] as well as test for 
heterogeneity based on Cochran’s Q statistic although this test is known for having poor statistical 
power [13]. 
  As a sensitivity analysis, several stratified analyses were conducted. To evaluate whether the 
risk differed by type of industry, workers were separated between tyre production, general rubber 
goods, and a mixed category for factories that manufactured both tyres and general rubber goods. 
The role of the period of first employment on the risk of death was also investigated separating 
workers employed before 1985 to those employed from 1985 onwards. 
The role of the duration of employment on the risk of death was investigated in a Poisson 
model with gender and a gender specific smooth function of duration of employment as explanatory 
variables, and the logarithm of the expected number of deaths as ‘offset’. Duration of employment 
was modelled with cubic natural splines and three degrees of freedom. Cut-points (knots) of 
duration of employment were built from duration of employment of deceased subjects, such as at 
least eight deaths occurred between two points. The knots for the spline were built in a way that the 
knots divide duration of employment in intervals that contain the duration of employment of eight 
deceased workers each. This enables a stable estimation of SMR while keeping enough points for 
modelling the splines for the parameter of duration. 
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All data were anonymised prior to statistical analysis. P-values below 5% were considered as 
statistically significant. 
 
 
Results 
 In the five European countries, a total 38,457 workers (29,768 men and 8,689 women) were 
included in the present study. Each country contributed rather homogeneously to the number of 
workers with Poland and the United Kingdom providing the greatest number of workers (Table 1). 
The average follow-up was 26 years and ranged from 18.7 years in Germany to 29.4 years in Poland, 
contributing to a total of 949,370 person-years of observation. The majority of workers (77.4%) were 
men. More women were recruited in Poland and Sweden. No major difference was observed 
between the cohorts assembled by each country. Overall, 2,725 deaths were observed during the 
follow-up. 
Table 2 shows observed deaths and SMRs for primary, secondary and exploratory outcomes for 
men, women and both genders combined. In men, there were significantly reduced SMRs for lung 
cancer, colorectal cancer, all cancers combined, all causes combined, and cardiovascular diseases. In 
women, there were significantly reduced SMRs for all cancers combined, all causes combined, and 
cardiovascular diseases. In the total study population (both genders combined), there were 
significantly reduced SMRs for lung cancer, colorectal cancer, all cancers combined, all causes 
combined, and cardiovascular diseases. 
Table 3 shows observed deaths and SMRs for primary and secondary outcomes for men, women and 
both genders combined, by industry sector. In the tyre sector, there were significantly reduced SMRs 
for lung cancer in men and in both genders combined, and for all cancers combined in men, women 
and both genders combined. There were no significant excesses. In the general rubber goods sector 
there were significantly elevated SMRs for stomach cancer in men and in both genders combined, 
and for multiple myeloma in men and both genders combined. There were no significant deficits. In 
the mixed sector, there were significantly reduced SMRs for all cancers combined in men and both 
genders combined. There were no significant excesses. 
  Based on 17 deaths observed during the follow-up, the risk of death from bladder cancer 
was SMR=0.80 (95%CI 0.46 to 1.38) with no evidence of heterogeneity between countries (Figure 1). 
This absence of increased risk for bladder cancer remained when stratified by gender (Table 2), 
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employment period (S-Table 2) and type of industry (Table 3). The risk of death from lung cancer was 
significantly decreased in rubber workers as compared to the general population with an SMR of 
0.81 (95%CI 0.70 to 0.94) with no heterogeneity between countries (Figure 2). 
  For all other cancer sites as well as all-cause mortality, cardiovascular and respiratory 
mortality, the risk of death was not significantly increased for neither men nor women (Table 2). On 
the contrary, a statistically significant decrease was observed for mortality from all causes of cancer 
total cancer mortality (SMR=0.81, 95%CI 0.76 to 0.87), all causes of death total mortality (SMR=0.81, 
95%CI 0.73 to 0.89), cardiovascular diseases (SMR=0.79, 95%CI 0.70 to 0.89), and for risk of death 
from colorectal cancer (SMR=0.72, 95%CI 0.55 to 0.94). Even if only eight deaths in men were 
observed for mesothelioma, the SMR was estimated for this cancer site and was 1.32 (95%CI 0.72 to 
2.43). The overall results were not affected by the correction factors applied to person-years in 
Germany to account for migration and risk of death in the 2001-2003 period with no follow-up 
information. 
 Workers in the tyre industry were hired at around the same age as workers in the general 
rubber goods industry (median age of hire being 23 and 25 years respectively), and they were 
followed for about the same duration (25 and 23.5 years respectively). However, workers in the tyre 
industry were more frequently men (80% men) than in the general rubber goods industry (74% 
men). The greatest difference was the duration of employment which was a median of 10.5 years in 
the tyre industry while it was 4.2 years in the general rubber good industry. When stratifying 
workers by type of industry, a clear difference could be observed between these two populations 
with lower SMR in the tyre industry as compared to general rubber goods (Table 3). For total cancer 
mortality the risk of death was SMR=0.68 (95%CI 0.60 to 0.76) among workers in the tyre industry 
while it was close to 1 in workers in the general rubber goods industry with an SMR of 1.03 (95%CI 
0.91 to 1.18) (Figure 3). In this stratified analysis, workers in the general rubber goods industries had 
a significant increased risk of stomach cancer (SMR=1.83, 95% CI 1.23 to 2.72) and multiple myeloma 
(SMR=3.18, 95% CI 1.61 to 6.27). Elevated SMRs were observed only among workers employed 
before 1985 (S-Table 2). These results were not consistent between countries and primarily driven 
by a majority of deaths in Poland for stomach cancer and a majority of deaths in the United Kingdom 
for multiple myeloma. 
 Workers employed from 1985 onwards had an apparently, though not significantly lower 
risk of total cancer mortality with a SMR of 0.74 (95%CI 0.65 to 0.84) as compared to workers 
employed before 1985 for which the SMR was 0.86 (95%CI 0.79 to 0.94). Such a decreased risk in 
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more recently employed workers was also observed for other primary and secondary outcomes (S-
Table 2). 
 The risk of death from any cause was further investigated in a Poisson regression with a 
spline function applied to the duration of employment. With a risk initially above the general 
population, especially among men and women in general rubber goods production, a marked 
decline of the risk of death was observed with increasing years of employment (Figure 4, S-Figure 2). 
This trend seemed slightly stronger in men but went in the same direction for women. A similar 
trend was observed when limiting the analysis to total cancer mortality (S-Figure 1). Although 
difficult to interpret because of small numbers, a similar trend was observed for lung cancer 
mortality. 
 
Discussion 
  In this cohort of workers in the rubber manufacturing industry first employed since 1975 in 
five European countries, there was no consistent indication of an increased risk of cancer mortality 
among the cancer sites pre-identified as primary or secondary outcomes of interest, i.e. total cancer 
mortality, and site-specific mortality for bladder, lung, stomach, leukaemia, myeloma and non-
Hodgkin’s lymphoma. In addition, none of the exploratory outcomes had their risk significantly 
increased. 
  There are a number of noticeable issues among a number of stratified analyses showing 
inconsistencies in the outcomes. In an analysis of secondary endpoints, when stratified by type of 
industry and period of first employment, excess risks of myeloma and gastric cancer were observed 
due, essentially, to results from the United Kingdom and Poland, respectively. Increases in risk of 
multiple myeloma and stomach cancer were observed mainly for the workers first employed before 
1985, but not workers employed more recently. It is likely possible that these increased risks, which 
are further decreasing in more recently exposed workers, are the result of decrease of exposure to 
carcinogens. However, these results should be interpreted with caution as they were not consistent 
across countries, gender and type of industry, and mainly driven by a few excess deaths observed in 
the United Kingdom for multiple myeloma and a few excess deaths observed in Poland for stomach 
cancer. 
  Lung cancer, one of the primary hypotheses of the study, showed decreased risks in most 
countries. Secondary outcomes such as colorectal cancer, total cancer mortality, all-cause mortality 
and cardiovascular diseases also showed decreased risks. The reduction of risks for causes of death 
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were lower for workers in the tyre industries than for the general rubber goods industries. Several 
factors could be responsible for such a reduced risk. Such a pattern of decreased risk could be the 
sign of a “healthy worker effect” [14] in particular because the observed numbers of deaths from 
any cause and for total cancer mortality were systematically lower than expected. The healthy 
worker effect is a classical bias in epidemiology of occupational mortality and results in biased 
estimation of SMR when mortality of workers is compared to mortality of the general population. Its 
impact could play at the inception of cohort of workers with a “healthy population selection effect” 
and during follow-up with a “survivor population effect” [15]. 
  In the cohorts of European rubber workers, a decreased risk of all-cause mortality is 
consistent with a healthy population selection effect, in particular because the follow-up started at 
recruitment in each cohort [16]. It has been suggested that the initial health advantage conferred by 
selection is expected to progressively dissipate with prolonged follow-up [16]. This would be in 
contradiction with the decreasing trend in SMR for longer duration of employment in rubber 
workers. However, staying active in the industry could be a secondary effect of selection with less 
healthy workers being more likely to be removed from hazardous exposure than healthier workers 
[17]. Longer duration in employment could be interpreted as a marker of improved economic status, 
better access to medical care and changes in life-style [18]. The healthy worker effect has been 
reported in previous studies on SMRs for cancer mortality [15, 17] but this bias usually affected less 
the SMRs for cancer than the SMRs for total mortality [15, 16]. In the present study, SMRs were 
significantly decreased for several cancer sites with values even lower than the total mortality. 
 The difference between tyre industry and general rubber goods could be an artefact with 
workers in the general rubber goods industry were employed for a shorter duration. However, the 
effect of type of industry and duration of employment seemed independent when conducting the 
spline regression separately by type on industry (S-Figure 2). This indicates that both working in the 
tyre industry and for a long duration were actually associated with a decreased risk of overall 
mortality. In contrast, in the general rubber goods industry a similar healthy worker effect was not 
evident for total mortality: elevated SMRs were evident up to 15 years duration of employment. 
 Rubber production is an occupation classified as group 1 carcinogen by IARC, without clear 
indication of what the responsible agent might be [4]. A particular focus has been made on tyre 
production, in particular the tyre curing process during which high temperatures are reached to 
stimulate reaction between different chemical compounds of the tyre. Measurements conducted 
with the European project ExAsRub [19] where the results can be consulted online 
(http://exasrub.iras.uu.nl/) revealed higher exposure to several agents in workers working in the 
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general rubber goods as compared to workers in the tyre industry. For example, in the period 1989-
1993 in the UK, personnal representative measurement of rubber dust was 2.82 mg/m3 (geometric 
mean) in the general rubber goods and 1.18 mg/m3 in the tyre industry. It could be hypothesised 
that the greater efforts in the tyre industry to decrease exposure to chemical agents was potentially 
strengthened with additional health measures such as anti-smoking policies in the workplace. The 
differences in the overall SMRs between tyre and general rubber goods sectors might also be due to 
differences in smoking habits, however no clear data was identified to confirm this hypothesis. 
  Major industries in Europe have experienced major changes in occupational hygiene through 
increased surveillance and actions to protect workers. In the rubber manufacturing industry, these 
changes seemed to have started earlier as the analysis of the data collected within the EU-ExAsRub 
consortium showed a c ntinuous decreasing time trends of inhalable dust from 1975 to 2005 
although there was national variation [6]. The results stratified by period of employment showed 
that decreased risks of lung cancer and total cancer mortality were even stronger after 1985 than 
before 1985 which is in line with data showing a progressive decline in exposure to inhalable dust 
measured in rubber industries in Europe. Caution must be expressed in interpreting these findings. 
Comparison with mortality data in the prospective cohort, whether overall or by subgroup (such as 
type of manufacturing), and the dust levels are on an ecological basis, a weak type of study design 
compared to the prospective cohort study reported here. 
  The findings from this study are reassuring. However, it is recommended that these cohorts 
continue to be monitored regularly to ensure that the absence of increased risk is maintained for 
longer follow-up, and the long-term positive effects of the continual implementation of technology 
innovations to reduce exposures to workers can be maintained. Longer follow-up will also allow 
examination of cohorts employed in more recent years (after 1985). In addition, it will allow more 
detailed evaluation of the healthy worker effect. 
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Legends to Figures 
 
 
Figure 1. Forest plot of the risk of bladder cancer mortality (men and women combined) from five 
cohorts of European rubber workers. Numbers of deaths are reported in brackets. The red line 
corresponds to a standardised mortality ratio (SMR) of 1, i.e., no difference in mortality between the 
cohort and the general population. The blue line corresponds to the SMR for all-cause mortality. 
 
 
Figure 2. Forest plot of the risk of lung cancer mortality (men and women combined) from five 
cohorts of European rubber workers. Numbers of deaths are reported in brackets. The red line 
corresponds to a standardised mortality ratio (SMR) of 1, i.e., no difference in mortality between the 
cohort and the general population. The blue line corresponds to the SMR for all-cause mortality. 
 
 
Figure 3. Forest plot of the risk of all cancers mortality (men and women combined) from five 
cohorts of European rubber workers in the tyre industry (red), in the general rubber goods (GRG) 
industry (blue) and in mixed industry (purple). Numbers of deaths are reported in brackets. The 
black line corresponds to a standardised mortality ratio (SMR) of 1, i.e., no difference in mortality 
between the cohort and the general population 
 
 
Figure 4. Analysis of risk of death from any cause from five cohorts of European rubber workers by 
duration of employment in the rubber manufacturing industry. The horizontal red line corresponds 
to the global SMR for all causes of death. The plain black lines represent the spline curve of SMR by 
duration of employment (bold line) with its 95% confidence interval (normal lines). 
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Table 1. Characteristics of the five European cohorts of workers first employed in the rubber manufacturing industry since 1975 
 Germany Italy Poland Sweden UK 
Number of workers 7616 5115 9700 7424 8602 
Number of factories 8 2 2 11 41 
Follow-up (years) 18.7 19.1 29.4 21.7 24.1 
Number of deaths 136 216 1451 376 546 
Gender (% Men) 85.9% 91.1% 63.2% 66.3% 87.4% 
Type of industry (%Tyre/%GRG/%Other*) 0/34.1/65.9 100/0/0 77.1/22.9/0 5.5/32.2/62.4 51.0/36.2/12.8 
Age of hire (Median, IQR) 24 (21; 29) 25 (22; 31) 21 (19; 26) 25 (20; 35) 25 (21; 33) 
Duration of Employment (Median, IQR) 5.3 (2.5; 10.5**) 10.7 (4.9; 16.3**) 7.4 (3.0; 17.2) 4.6 (2.2; 10.3**) 4.9 (2.6; 12.7) 
Date of first recruitment 05/01/1981 01/01/1975 01/01/1975 01/01/1975 01/01/1982 
Date of Last Follow-up 31/12/2012 (LS) 
or 31/12/2013 
(NRW) 
31/03/2013 30/06/2012 31/12/2011 31/12/2011 
Date of last job history update 31/12/2000 31/03/2013 31/10/2011 01/07/2002 - 31/12/2011 
(4005 
subjects/47%) 
- variable 
between 1988 
and 1995 (4597 
subjects/53%) 
% Still employed at last job history update 51.2% 46.4% 0.5% 44.8% 
 
- Last job history 
update 2011: 
14.5% among 
4005 subjects 
LS: Lower Saxony; NRW: North Rhine-Westphalia; GRG: general rubber goods 
*Other includes mixed factories (both tyre and GRG) 
**: not estimable as more than 25% of workers were still employed at the last job history update  
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Table 2. Observed deaths and standardised mortality ratios (SMRs) among 38,457 workers first employed in the European rubber manufacturing 
industry since 1975, by gender. 
 Men (N=29,768; PY=714,612) Women (N=8,689; PY=234,758) Combined (N=38,457; PY=949,370) 
Cause of deaths Observed SMR (95% CI) Observed  SMR (95% CI) Observed  SMR (95% CI) 
Primary outcomes       
  Bladder cancer 16 0.87 (0.49; 1.52) 1 0.36 (0.06; 2.29) 17 0.80 (0.46; 1.38) 
  Lung cancer 157 0.80 (0.68; 0.94) 29 0.91 (0.61; 1.35) 186 0.81 (0.70; 0.94) 
Secondary outcomes       
  All cancers 582 0.81 (0.74; 0.88) 187 0.83 (0.72; 0.97) 769 0.81 (0.76; 0.87) 
  Stomach cancer 47 1.15 (0.84; 1.56) 10 1.23 (0.61; 2.46) 57 1.16 (0.88; 1.53) 
  Leukaemia 18 0.97 (0.58; 1.63) 4 0.76 (0.14; 4.02) 22 0.84 (0.53; 1.35) 
  Non-Hodgkin’s lymphoma 14 0.74 (0.40; 1.37) 4 0.85 (0.28; 2.57) 18 0.79 (0.47; 1.34) 
  Multiple myeloma 12 1.55 (0.81; 2.98) 4 1.68 (0.56; 5.11) 16 1.54 (0.89; 2.68) 
Exploratory outcomes**       
  All causes of death 2259 0.80 (0.71; 0.89)* 466 0.86 (0.78; 0.94) 2725 0.81 (0.73; 0.89)* 
  Cardiovascular diseases 655 0.80 (0.71; 0.90) 110 0.75 (0.61; 0.90) 765 0.79 (0.70; 0.89) 
  Respiratory diseases excluding pneumonia 68 0.93 (0.72; 1.19) 12 0.74 (0.38; 1.42) 80 0.90 (0.71; 1.13) 
  Brain and central nervous system cancer 33 0.95 (0.66; 1.39) 9 0.99 (0.46; 2.14) 42 0.96 (0.69; 1.34) 
  Colorectal cancer 39 0.61 (0.44; 0.86) 20 1.16 (0.71; 1.91) 59 0.72 (0.55; 0.94) 
  Kidney cancer 18 0.83 (0.49; 1.38) 3 - 21 0.82 (0.51; 1.32) 
  Larynx cancer 17 1.18 (0.69; 2.04) 0 - 17 1.12 (0.65; 1.93) 
  Liver cancer 15 0.73 (0.40; 1.31) 2 - 17 0.69 (0.40; 1.20) 
  Melanoma 11 0.88 (0.45; 1.71) 1 - 12 0.68 (0.36; 1.28) 
  Oesophagus 23 0.90 (0.57; 1.41) 1 - 24 0.84 (0.54; 1.30) 
  Oral cavity and pharynx 23 0.97 (0.62; 1.53) 1 - 24 0.92 (0.59; 1.43) 
  Pancreas cancer 33 0.93 (0.64; 1.36) 13 1.31 (0.70; 2.44) 46 0.98 (0.72; 1.35) 
  Prostate cancer 26 0.79 (0.52; 1.21) - - - - 
  Breast cancer 1 - 36 0.86 (0.60; 1.23) - - 
  Cervical cancer - - 17 1.25 (0.74; 2.10) - - 
  Ovarian cancer - - 12 0.73 (0.38; 1.40) - - 
Statistically significant associations are in bold 
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* Significant heterogeneity between the five countries (p<0.05) 
** Results of exploratory analysis with less than 5 deaths observed were not reported 
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Table 3. Observed deaths and standardised mortality ratios by type of industry among 38,457 workers first employed in the European rubber 
manufacturing industry since 1975, by industry sector 
 Tyre  General rubber goods  Mixed  
Cause of deaths Observed SMR (95% CI) Observed SMR (95% CI) Observed SMR (95% CI) 
Men N=13,962; PY=359,318 N=7,684; PY=185,206 N=8,122; PY=170,021 
  Bladder cancer ¤ 9 1.03 (0.48; 2.20) 6 0.84 (0.32; 2.18) 1 0.23 (0.03; 1.90) 
  Lung cancer¤ 72 0.72 (0.57; 0.92) 67 0.95 (0.74; 1.23) 18 0.78 (0.47; 1.31) 
  All cancers 235 0.67 (0.59; 0.77) 263 1.05 (0.92; 1.19) 84 0.70 (0.56; 0.88) 
  Stomach cancer 20 0.97 (0.60; 1.57) 24 1.75 (1.12; 2.71) 3 0.58 (0.12; 2.75) 
  Leukaemia 11 1.15 (0.60; 2.19) 6 0.84 (0.34; 2.08) 1 0.14 (0.02; 1.15) 
  Non-Hodgkin’s lymphoma 6 1.12 (0.21; 5.93) 6 0.95 (0.35; 2.64) 2 0.44 (0.08; 2.57) 
  Multiple myeloma 3 0.94 (0.25; 3.55) 8 3.02 (1.40; 6.51) 1 0.32 (0.04; 2.68) 
Women N=3,437; PY=107,540 N=2,628; PY=68,544 N=2,624; PY=58,672 
  Bladder cancer ¤ 0 0.00 (0.01; 2.98) 0 0.00 (0.01; 1.62) 1 1.30 (0.14; 11.92) 
  Lung cancer¤ 8 0.61 (0.29; 1.26) 16 1.68 (0.96; 2.92) 5 0.63 (0.23; 1.73) 
  All cancers 66 0.68 (0.53; 0.88) 80 1.01 (0.74; 1.38) 41 0.85 (0.61; 1.17) 
  Stomach cancer 3 0.64 (0.19; 2.19) 5 2.07 (0.77; 5.59) 2 1.37 (0.23; 8.14) 
  Leukaemia 1 0.29 (0.04; 2.29) 1 0.36 (0.05; 2.51) 2 0.84 (0.04; 16.90) 
  Non-Hodgkin’s lymphoma 1 0.45 (0.06; 3.56) 2 1.08 (0.20; 5.81) 1 0.54 (0.06; 4.73) 
  Multiple myeloma 2 1.69 (0.37; 7.73) 2 1.08 (0.12; 9.56) 0 0.00 (0.01; 2.56) 
Men and Women combined N=17,399; PY=466,858 N=10,312; PY=253,750 N=10,746; PY=228,693 
  Bladder cancer ¤ 9 0.97 (0.46; 2.08) 6 0.76 (0.29; 1.98) 2 0.50 (0.11; 2.30) 
  Lung cancer¤ 80 0.71 (0.56; 0.90) 83 1.02 (0.81; 1.29) 23 0.73 (0.47; 1.14) 
  All cancers 301 0.68 (0.60; 0.76) 343 1.03 (0.91; 1.18) 125 0.74 (0.61; 0.88) 
  Stomach cancer 23 0.92 (0.59; 1.44) 29 1.83 (1.23; 2.72) 5 0.71 (0.24; 2.13) 
  Leukaemia 12 0.96 (0.52; 1.78) 7 0.80 (0.35; 1.84) 3 0.60 (0.15; 2.37) 
  Non-Hodgkin’s lymphoma 7 1.08 (0.24; 4.90) 8 1.08 (0.46; 2.50) 3 0.50 (0.13; 1.99) 
  Multiple myeloma 5 1.12 (0.41; 3.04) 10 3.18 (1.61; 6.27) 1 0.25 (0.03; 2.06) 
Statistically significant associations are in bold  
¤: Primary outcomes; *: significant heterogeneity between studies
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Figure 1. Forest plot of the risk of bladder cancer mortality (men and women combined) from five 
cohorts of European rubber workers. Numbers of deaths are reported in brackets. The red line 
corresponds to a standardised mortality ratio (SMR) of 1, i.e., no difference in mortality between 
the cohort and the general population. The blue line corresponds to the SMR for all-cause 
mortality. 
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Figure 2. Forest plot of the risk of lung cancer mortality (men and women combined) from five 
cohorts of European rubber workers. Numbers of deaths are reported in brackets. The red line 
corresponds to a standardised mortality ratio (SMR) of 1, i.e., no difference in mortality between 
the cohort and the general population. The blue line corresponds to the SMR for all-cause 
mortality. 
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Figure 3. Forest plot of the risk of all cancers mortality (men and women combined) from five 
cohorts of European rubber workers in the tyre industry (red), in the general rubber goods (GRG) 
industry (blue) and in mixed industry (purple). Numbers of deaths are reported in brackets. The 
black line corresponds to a standardised mortality ratio (SMR) of 1, i.e., no difference in mortality 
between the cohort and the general population 
 
Page 22 of 26Annals of Oncology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
22 
 
     Men          Women 
 
Figure 4. Analysis of risk of death from any cause from five cohorts of European rubber workers by duration of employment in the rubber manufacturing 
industry. The horizontal red line corresponds to the global SMR for all causes of death. The plain black lines represent the spline curve of SMR by 
duration of employment (bold line) with its 95% confidence interval (normal lines). 
 
Page 23 of 26 Annals of Oncology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
23 
 
Appendix 
S-Table 1. List of ICD codes used for classifying deaths in the five countries 
Cause of death ICD8 ICD9 ICD10 
Primary outcomes    
Bladder cancer 188 188 C67 
Lung cancer 162 162 C33-C34 
Secondary outcomes    
All cancers 140-209 140-208 C00-C97 
Stomach cancer 151 151 C16 
Leukaemia 204-207 204-208 C91-C95 
Non-Hodgkin's lymphoma 200, 202  200, 202 C82-C86  
Multiple myeloma 203 203 C90  
Exploratory analyses    
Other diseases    
All causes  000-796 001-799 A00-R99 
Cardiovascular diseases 390-458 390-455 I00-I99 
Respiratory diseases without 
pneumonia 
460-474, 490-
519 
460-478, 
487-519 
J00-J11, J19-J99 
Cancers    
Brain and central nervous system 191-192 191-192 C47, C70-C72 
Colorectal cancer  153-154 153-154 C18-C21 
Kidney  189 189 C64-C66, C68 
Larynx  161 161 C32 
Liver with unspecified liver cancers 155, 197.8 155 C22 
Melanoma  172 172 C43 
Oesophagus 150 150 C15 
Oral cavity and pharynx  140-149  140-149  C00-C14 
Pancreas  157 157 C25 
Prostate  185 185 C61 
Breast  174 174 C50  
Cervix  180 180 C53 
Ovary  183 183 C56-C57 
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S-Table 2. Standardised mortality ratios by year of hire for 38,457 workers first employed in the European rubber manufacturing industry since 1975 
 Employed before 1985  Employed from 1985 onwards  
Cause of deaths Observed SMR (95% CI) Observed SMR (95% CI) 
Men N= 10,086; PY=307,721 N= 19,682; PY=406,891 
  Bladder cancer¤ 10 0.81 (0.38; 1.71) 6 1.05 (0.42; 2.66) 
  Lung cancer¤ 112 0.84 (0.69; 1.02) 45 0.78 (0.56; 1.08) 
  All cancers 380 0.85 (0.76; 0.94) 202 0.75 (0.65; 0.86) 
  Stomach cancer 36 1.35 (0.95; 1.92) 11 0.98 (0.50; 1.95) 
  Leukaemia 13 1.26 (0.70; 2.26) 5 0.48 (0.17; 1.35) 
  Non-Hodgkin’s lymphoma 8 0.87 (0.36; 2.07) 6 0.61 (0.25; 1.48) 
  Multiple myeloma 7 1.61 (0.65; 3.96) 5 1.29 (0.46; 3.65) 
Women N= 4,462; PY=145,661 N= 4,227; PY=89,097 
  Bladder cancer¤ 0 0.00 (0.01; 1.07) 1 1.06 (0.15; 7.37) 
  Lung cancer¤ 21 0.98 (0.61; 1.57) 8 0.74 (0.32; 1.70) 
  All cancers 143 0.90 (0.76; 1.06) 44 0.71 (0.51; 0.97) 
  Stomach cancer 9 1.46 (0.70; 3.03) 1 0.33 (0.05; 2.07) 
  Leukaemia 2 0.47 (0.06; 3.83) 2 0.97 (0.20; 4.79) 
  Non-Hodgkin’s lymphoma 3 0.82 (0.22; 2.97) 1 0.43 (0.07; 2.78) 
  Multiple myeloma 4 2.29 (0.60; 8.76) 0 0.00 (0.01; 1.80) 
Both genders N= 14,548; PY=453,382 N= 23,909; PY=495,988 
  Bladder cancer¤ 10 0.73 (0.35; 1.54) 7 1.08 (0.44; 2.63) 
  Lung cancer¤ 133 0.85 (0.71; 1.02) 53 0.76 (0.57; 1.02) 
  All cancers 523 0.86 (0.79; 0.94) 246 0.74 (0.65; 0.84) 
  Stomach cancer 45 1.37 (1.00; 1.88) 12 0.93 (0.47; 1.81) 
  Leukaemia 15 1.06 (0.61; 1.84) 7 0.61 (0.25; 1.49) 
  Non-Hodgkin’s lymphoma 11 0.91 (0.45; 1.84) 7 0.65 (0.29; 1.48) 
  Multiple myeloma 11 1.81 (0.88; 3.71) 5 1.11 (0.39; 3.13) 
Statistically significant associations are in bold  
¤: primary outcomes
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S-Figure 1. Analysis of risk of death from cancer from five cohorts of European rubber workers by duration of employment in the rubber manufacturing 
industry. The horizontal red line corresponds to the global SMR for cancer death. The black lines represent the spline curve of SMR by duration of 
employment (bold line) with its 95% confidence interval (normal lines). 
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S-Figure 2. Analysis of risk of death from any cause from five cohorts of European rubber workers by duration of employment in the rubber 
manufacturing industry. The plain blue line represents the spline curve of SMR for workers in the general rubber goods industry by duration of 
employment with its 95% confidence interval (blue area). The plain red line represents the spline curve of SMR for workers in the tyre industry by 
duration of employment with its 95% confidence interval (red area). 
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